Unique Physique publishes two incompatible lists of the states it cannot serve, sells a one-month NAD+ supply whose own dosing instructions run past a month, and heads a prescription injection with the word supplement. Neither weight-loss molecule is named anywhere on its pricing pages, so neither has a price here.
What Unique Physique charges
NAD+: $200 — sold as a one-month supply, but the ten syringes shipped cover five or ten weeks depending on which of its two dosing schedules is prescribed
Unique Physique is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
Two exclusion lists, one overlapping state
Its pricing page says it is available nationwide except for Alaska, California, Kansas and Wisconsin.
Its terms say it is authorised to provide services in all states except Wisconsin and Nebraska.
Only Wisconsin appears in both. No states are recorded here, because no two of the seller's own sentences agree on which ones they are.
A one-month supply that does not last a month, or lasts three
The NAD+ listing reads "1 mo supply. Dosage: 30 day BUD. Will be prescribed as 1 ml twice weekly OR 1 ml weekly. Patients will be shipped 10 syringes."
Ten syringes is five weeks of medicine at twice weekly and ten weeks at once weekly, against a thirty-day beyond-use date. Neither schedule fits the month it is sold as.
The seller concedes the gap itself: "Patients may choose to do once weekly dosage will not be refunded or have meds replaced that go beyond the intended use date." So the shortfall is disclosed, and the risk is placed on the buyer.
Programme prices that name no drug
It publishes two weight-loss programme figures.
Neither semaglutide nor tirzepatide appears anywhere on its pricing page, its weight-loss medications page, its FAQ or its services pages.
A figure attached to a programme with no named drug is not a drug price, so nothing is filed for either molecule.
A prescription product under the word supplement
The NAD+ listing is headed "NAD+ Injectible Supplement" on a prescription telehealth page.
Its own copy elsewhere describes clinicians reviewing signs and symptoms and deciding between brand-name weight-loss medications and a compounded version, and says "As a medical practice, not a retail pharmacy, our clinicians conduct comprehensive evaluations".
So the seller describes itself as a medical practice while labelling a prescription injection the way a shelf product is labelled. It names no dispensing pharmacy.
Who it's for
Readers who want the syringe count and the beyond-use date stated before ordering.
Buyers who prefer a seller that names the states it cannot reach.
Shoppers who want the dosing schedule printed beside the price.
Anyone who values a written statement of what happens if a vial is used past its date.
Who should look elsewhere
Buyers shopping either weight-loss molecule, since neither is named on any pricing page.
Readers who need one reliable answer about whether their state is served.
Anyone who expects a one-month supply to cover a month.
Shoppers who want the dispensing pharmacy named.
Strengths
Publishes its dosing schedule, its syringe count and its beyond-use date beside the price
Says plainly that it is a medical practice and not a retail pharmacy
Names the states it cannot serve rather than only the ones it can
Concedes in writing what happens if a patient uses the vial past its date
Trade-offs
Its pricing page and its terms name two different, incompatible lists of excluded states
Its one-month supply ships enough syringes for five or ten weeks, past its own beyond-use date
Neither weight-loss molecule is named anywhere on its pricing pages, so neither has a price
Markets a prescription injection under the word supplement
How we verified this
Read both exclusion lists in their own documents, compared them state by state, found one state in common, and recorded no state list at all.
Worked the syringe count against both dosing schedules the listing offers and against its own beyond-use date, and recorded the mismatch with the seller's own concession beside it.
Searched its pricing, weight-loss, FAQ and services pages for either molecule by name, found neither, and filed no price for either.
Requested a deliberately meaningless address on this host in the same session and confirmed it returns a not-found response.
Screened the brand against the live federal warning-letter table through a matcher that normalises both the query and the filed company name before comparing, and found no letters.
A provider to compare Unique Physique against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
Its own pages give two incompatible answers. The pricing page excludes four states, the terms exclude two, and only Wisconsin appears on both lists. Nothing is recorded here because the seller does not agree with itself.
How long does the NAD+ order actually last?
It is sold as a one-month supply and ships ten syringes. At twice weekly that is five weeks, at once weekly ten, and the beyond-use date is thirty days. The seller says medicine used past that date is not refunded or replaced.
What does semaglutide or tirzepatide cost here?
Neither drug is named anywhere on its pricing or weight-loss pages. It publishes two programme figures with no molecule attached, which is not a price for either drug.
Is the NAD+ injection a supplement?
It is headed that way on the listing, but it is sold on a prescription telehealth page by a business that describes itself as a medical practice rather than a retail pharmacy.
Unique Physique is not a paid partner; this link may earn a commission if that changes. Full disclosure.